New Drugs: Antisense Oligodeoxynucleotides as Clinical Therapeutic Agents

This publication has 72 references indexed in Scilit:

• Antisense oligodeoxynucleotides
  Current Opinion in Oncology, 1994
• Cationic Lipids Improve Antisense Oligonucleotide Uptake and Prevent Degradation in Cultured Cells and in Human Serum
  Biochemical and Biophysical Research Communications, 1993
• An Antisense Oligodeoxynucleotide Approach to Investigate the Function of the Nuclear-Encoded Subunits of Human Cytochrome c Oxidase
  Biochemical and Biophysical Research Communications, 1993
• Autoinduction of Platelet Derived Growth Factor (PDGF) A-Chain mRNA Expression in a Human Malignant Melanoma Cell Line and Growth Inhibitory Effects of PDGF-A-Chain mRNA-Specific Antisense Molecules
  Biochemical and Biophysical Research Communications, 1993
• Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
  Science, 1993
• Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide
  Biochemical and Biophysical Research Communications, 1992
• EGF antisense oligodeoxynucleotides block murine odontogenesis in vitro
  Developmental Biology, 1991
• Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents
  Nature, 1991
• Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense Oligomer
  Science, 1990
• Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones.
  The Journal of Experimental Medicine, 1988